Page last updated: 2024-08-21

alpha-fluoro-beta-alanine and Breast Cancer

alpha-fluoro-beta-alanine has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridgewater, J; Grange, S; Kimura, M; Kuranami, M; Lucraft, H; McAleer, J; Monkhouse, J; Poole, C; Reigner, B; Saeki, T; Sasaki, Y; Schüller, J; Watanabe, T; Weidekamm, E; Yorulmaz, C1
Diasio, RB; Schuetz, JD; Sommadossi, JP; Wallace, HJ1

Trials

1 trial(s) available for alpha-fluoro-beta-alanine and Breast Cancer

ArticleYear
Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:3

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Area Under Curve; beta-Alanine; Biotransformation; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Half-Life; Humans; Japan; Metabolic Clearance Rate; Middle Aged; Tissue Distribution; White People

2003

Other Studies

1 other study(ies) available for alpha-fluoro-beta-alanine and Breast Cancer

ArticleYear
Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
    Cancer research, 1985, Volume: 45, Issue:10

    Topics: Animals; Antineoplastic Agents; beta-Alanine; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line; Cell Survival; Female; Fluorouracil; Humans; Male; Mice; Mice, Inbred Strains; Thymidylate Synthase

1985